Page last updated: 2024-08-25

ropivacaine and Uterine Cervical Neoplasms

ropivacaine has been researched along with Uterine Cervical Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Cao, Y; Chen, L; Cheng, D; Dai, Q; Dai, W; Gu, E; Li, F; Liu, X; Tan, Q; Wei, Z; Xu, G; Yang, Z; Zhang, J; Zhang, L; Zhu, S; Zuo, Y1
Chen, X; Guo, X; Huang, S; Liu, W; Song, X1
Harrison, GR1

Other Studies

3 other study(ies) available for ropivacaine and Uterine Cervical Neoplasms

ArticleYear
Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief.
    Theranostics, 2020, Volume: 10, Issue:11

    Topics: Anesthetics, Local; Animals; Autophagy; Caloric Restriction; Cancer Pain; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Female; Humans; Liposomes; Male; Melanoma; Mice; Mice, Inbred C57BL; Ropivacaine; Sciatic Nerve; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A

2020
Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis.
    Oncology reports, 2020, Volume: 43, Issue:5

    Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Phosphorylation; Protein Tyrosine Phosphatases, Non-Receptor; Ropivacaine; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation; Uterine Cervical Neoplasms

2020
The use of epidural ropivacaine in high doses for the management of pain from invasive carcinoma of the cervix.
    Anaesthesia, 1999, Volume: 54, Issue:5

    Topics: Adult; Amides; Analgesia, Epidural; Analgesia, Patient-Controlled; Anesthetics, Local; Female; Humans; Pain, Intractable; Palliative Care; Ropivacaine; Uterine Cervical Neoplasms

1999